Movement Alert｜METIS TECHBIO-P falls 5.6% in Regular Trading, Biotechnology Sector Remains Under Pressure

Market Focus10-14

On October 14, METIS TECHBIO-P falls 5.6% in Regular Trading, trading at HK$11.13, with turnover of HK$37.53 million.

The move aligns with continued weakness across Hong Kong-listed biotechnology shares, where AI drug discovery names remained under pressure and sector-wide correction was cited as the main driver.

Recent public disclosures indicated the company posted interim revenue of RMB154 million, surging 13,399% year over year, while adjusted net loss narrowed 56.4% to RMB51 million. Even so, recent changes in US rate expectations have continued to weigh on long-duration, pre-profit biotech companies, overshadowing the company’s improving fundamentals in the near term.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment